4.3 Article Proceedings Paper

MPTP as a mitochondrial neurotoxic model of Parkinson's disease

Journal

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
Volume 36, Issue 4, Pages 375-379

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1023/B:JOBB.0000041771.66775.d5

Keywords

MPTP; Parkinson's disease; neurodegeneration; mitochondria; oxidative stress; ATP depletion; programmed cell death

Funding

  1. NIA NIH HHS [R01 AG021617-01] Funding Source: Medline
  2. NINDS NIH HHS [P01 NS11766-27A1, P50 NS38370, R01 NS38586, R29 NS37345, NS42269] Funding Source: Medline

Ask authors/readers for more resources

1-Methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a potent neurotoxin extensively used to model Parkinson's disease (PD). A cascade of deleterous events, in which mitochondria play a pivotal role, drives MPTP neurotoxicity. How mitochondria are affected by MPTP and how their defect contributes to the demise of dopaminergic neurons in this model of PD are discussed in this review.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available